top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

John Newland Biography and Net Worth

CFO of PetIQ

Mr. Newland has served as our Chief Financial Officer since 2014. Since joining PetIQ, Mr. Newland facilitated the move from a regional auditor to KPMG, implemented enhanced control systems and standards across the company and upgraded our finance and operations organizations. Prior to joining PetIQ, Mr. Newland gained extensive retail and consumer products experience working for Albertson’s and SuperValu in a range of finance roles. Mr. Newland is a retired fighter pilot and Commander in the Idaho Air National Guard, where he served from 1985 to 2013. Mr. Newland holds a Bachelor of Science degree in corporate finance from the University of Idaho and is a graduate of the United States Air Force Air War College.

What is John Newland's net worth?: The estimated net worth of John Newland is at least $975,881.66 as of July 21st, 2021. Mr. Newland owns 58,682 shares of PetIQ stock worth more than $975,882 as of April 24th. This net worth approximation does not reflect any other investments that Mr. Newland may own. Learn More about John Newland's net worth.
How do I contact John Newland?: The corporate mailing address for Mr. Newland and other PetIQ executives is 923 S. Bridgeway Pl., EAGLE ID, 83616. PetIQ can also be reached via phone at (208) 939-8900 and via email at [email protected]. Learn More on John Newland's contact information.
Has John Newland been buying or selling shares of PetIQ?: John Newland has not been actively trading shares of PetIQ over the course of the past ninety days. Most recently, John Newland sold 4,500 shares of the business's stock in a transaction on Wednesday, July 21st. The shares were sold at an average price of $36.69, for a transaction totalling $165,105.00. Following the completion of the sale, the chief financial officer now directly owns 58,682 shares of the company's stock, valued at $2,153,042.58. Learn More on John Newland's trading history.
Who are PetIQ's active insiders?: PetIQ's insider roster includes McCord Christensen (CEO), Robert Herrman (General Counsel), Ronald Kennedy (Director), John Newland (CFO), Susan Sholtis (President), and Michael Smith (EVP). Learn More on PetIQ's active insiders.

John Newland Insider Trading History at PetIQ

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/21/2021	Sell	4,500	$36.69	$165,105.00	58,682
6/21/2021	Sell	4,500	$40.00	$180,000.00	63,182
5/21/2021	Sell	4,500	$40.10	$180,450.00
4/21/2021	Sell	4,500	$40.80	$183,600.00	75,284
3/22/2021	Sell	4,500	$36.00	$162,000.00	76,682
1/21/2021	Sell	9,000	$36.00	$324,000.00	77,329
12/28/2020	Sell	9,000	$36.00	$324,000.00	86,329
11/12/2019	Buy	44,000	$22.28	$980,320.00	44,000
1/16/2019	Sell	5,500	$29.00	$159,500.00
12/10/2018	Sell	5,500	$31.11	$171,105.00
12/3/2018	Sell	11,000	$31.65	$348,150.00
9/17/2018	Sell	5,500	$40.76	$224,180.00
9/4/2018	Sell	42,778	$40.15	$1,717,536.70
8/24/2018	Sell	27,222	$40.00	$1,088,880.00
8/13/2018	Sell	5,500	$26.78	$147,290.00
7/17/2018	Sell	5,500	$26.03	$143,165.00
6/27/2018	Sell	11,000	$25.25	$277,750.00
6/21/2018	Sell	5,500	$24.53	$134,915.00
3/19/2018	Sell	5,500	$24.83	$136,565.00

John Newland Buying and Selling Activity at PetIQ

PetIQ Company Overview

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.

Today's Range

Now: $16.53

$16.45

$16.67

50 Day Range

MA: $17.39

$15.55

$19.04

2 Week Range

Now: $16.53

$11.26

$22.98

Volume

167,651 shs

Average Volume

283,258 shs

Market Capitalization

$486.48 million

P/E Ratio

275.55

Dividend Yield

N/A

Beta

1.64